Loading company…
Vistapath Biosystems automates pathology specimen processing with computer vision and AI.
Founded in 2017, Vistapath Biosystems is based in Cambridge, US, and serves hospitals, contract research organizations and life sciences companies. Its platform uses computer vision and artificial intelligence to support tissue inspection, inking, measurement and reporting. In June 2022, it raised USD 4 million in seed funding led by Moxxie Ventures, with First Star Ventures and NextGen Venture Partners participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in